EcoDrugPlus

Aldose Reductase-Like

Ensembl ID : ENSPNAG00000016436
Gene Symbol: LOC108437938
3 Cross references
344 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSPNAG00000003416
Gene Symbol: LOC108437939
3 Cross references
280 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSPNAG00000007911
Gene Symbol: LOC108430341
3 Cross references
202 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSPNAG00000018765
Gene Symbol: LOC108440671
3 Cross references
174 Possible Orthologues:

Alpha-2c Adrenergic Receptor-Like

Ensembl ID : ENSPNAG00000013950
Gene Symbol: LOC108434767
3 Cross references
160 Possible Orthologues:

Alpha-Synuclein-Like

Ensembl ID : ENSPNAG00000026054
Gene Symbol: LOC108412723
2 Cross references
189 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSPNAG00000022370
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amine Oxidase Copper Containing 3

Ensembl ID : ENSPNAG00000002957
Gene Symbol: AOC3
3 Cross references
411 Possible Orthologues:

Amylase Alpha 1b

Ensembl ID : ENSPNAG00000003252
Gene Symbol: AMY1B
4 Cross references
213 Possible Orthologues:

Amyloid Beta A4 Protein-Like

Ensembl ID : ENSPNAG00000019164
Gene Symbol: LOC108426075
3 Cross references
205 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSPNAG00000010344
Gene Symbol: APP
4 Cross references
203 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSPNAG00000001057
Gene Symbol: AR
3 Cross references
212 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).